KEROS THERAPEUTICS INC

Ticker: KROS CUSIP: 492327101 Class: Common Stock

Fairmount Funds Management LLC's Holding History (CIK: 0001802528)

Note: Option positions (PUT/CALL) are excluded.

Q3 2022

Shares 272,498 Value ($000) $10,251 Avg Close $34.66 Range $26.34 - $42.15

Q2 2022

Shares 272,498 Value ($000) $7,529 Avg Close $43.88 Range $24.38 - $68.29

Q1 2022

Shares 396,911 Value ($000) $21,584 Avg Close $51.33 Range $39.75 - $60.42

Q4 2021

Shares 292,833 Value ($000) $17,134 Avg Close $49.87 Range $36.13 - $63.47

Q3 2021

Shares 149,333 Value ($000) $5,908 Avg Close $35.59 Range $28.50 - $44.87

Q2 2021

Shares 149,333 Value ($000) $6,342 Avg Close $54.17 Range $41.88 - $71.74

Q1 2021

Shares 109,333 Value ($000) $6,729 Avg Close $63.36 Range $51.48 - $75.99

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2022	272,498	$10,251	$34.66	$26.34 - $42.15
Q2 2022	272,498	$7,529	$43.88	$24.38 - $68.29
Q1 2022	396,911	$21,584	$51.33	$39.75 - $60.42
Q4 2021	292,833	$17,134	$49.87	$36.13 - $63.47
Q3 2021	149,333	$5,908	$35.59	$28.50 - $44.87
Q2 2021	149,333	$6,342	$54.17	$41.88 - $71.74
Q1 2021	109,333	$6,729	$63.36	$51.48 - $75.99